Despite the market’s recent drop brought on by concerns over escalating trade tensions between the U.S. and China, it is hard for investors to find value plays amongst stocks. There is, however, still value to be had – and today’s article highlights three undervalued stocks to consider. Among them is a mid-cap stock carving out a niche in what the author notes “is the fastest-growing space within the pharmaceutical industry”: oncology. For more on these three value stocks, CLICK HERE.
Outstanding Bargains, Uncovered
- by Bob Mitchell
Tags:Chinese InvestorsInvestinvestorsMid-Cap StocksPharmaceutical InvestmentsStock MarketstocksTradesU.S. Investors